Local control and toxicity in a large cohort of central lung tumors treated with stereotactic body radiation therapy

International Journal of Radiation Oncology Biology Physics

Volumn 90, Issue 5, 2014, Pages 1168-1176

  Modh, Ankit ^a   Rimner, Andreas ^a   Williams, Eric ^a   Foster, Amanda ^a   Shah, Mihir ^a   Shi, Weiji ^a   Zhang, Zhigang ^a   Gelblum, Daphna Y ^a   Rosenzweig, Kenneth E ^b   Yorke, Ellen D ^a   Jackson, Andrew ^a   Wu, Abraham J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL ORGANS; DOSIMETRY; MULTIVARIANT ANALYSIS; RADIOTHERAPY; RISK ASSESSMENT; RISK PERCEPTION; TUMORS;

BIOLOGICALLY EFFECTIVE DOSE; ESOPHAGEAL TOXICITIES; INTENSITY MODULATED RADIATION THERAPY; METHODS AND MATERIALS; MULTIVARIATE ANALYSIS; NON SMALL CELL LUNG CANCER; PLANNING TARGET VOLUMES; STEREOTACTIC BODY RADIATION THERAPY;

TOXICITY;

ADULT; AGED; CANCER CONTROL; CARDIOTOXICITY; CONFERENCE PAPER; COUGHING; DOSIMETRY; DYSPNEA; ESOPHAGITIS; FEMALE; FOLLOW UP; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LUNG METASTASIS; LUNG TOXICITY; MAJOR CLINICAL STUDY; MALE; NON SMALL CELL LUNG CANCER; RADIATION DOSE; RADIATION PNEUMONIA; STEREOTACTIC BODY RADIATION THERAPY; TRACHEOBRONCHIAL TREE; TUMOR LOCALIZATION; TUMOR VOLUME; VERY ELDERLY; ADVERSE EFFECTS; CARCINOMA, NON-SMALL-CELL LUNG; ESOPHAGUS; LUNG; LUNG NEOPLASMS; MIDDLE AGED; ORGANS AT RISK; PATHOLOGY; PROCEDURES; PROPORTIONAL HAZARDS MODEL; RADIATION INJURY; RADIATION RESPONSE; RADIOSURGERY; RETROSPECTIVE STUDY; SECONDARY; TREATMENT FAILURE; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; ESOPHAGUS; FEMALE; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; ORGANS AT RISK; PROPORTIONAL HAZARDS MODELS; RADIATION INJURIES; RADIOSURGERY; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; TREATMENT FAILURE;

EID: 84920144171     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2014.08.008     Document Type: Conference Paper

References (26)

1. A.J. Fakiris, R.C. McGarry, and C.T. Yiannoutsos Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: Four-year results of a prospective phase II study Int J Radiat Oncol Biol Phys 75 2009 677 682
2. R. Timmerman, R. Paulus, and J. Galvin Stereotactic body radiation therapy for inoperable early stage lung cancer JAMA 303 2010 1070 1076
3. R. Timmerman, R. McGarry, and C. Yiannoutsos Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer J Clin Oncol 24 2006 4833 4839
4. Bezjak A. Stereotactic body radiation therapy in treating patients with stage I non-small cell lung cancer. Available at: http://clinicaltrials.gov/show/NCT00750269. Last accessed August 4, 2014.
5. R. Mohan, G. Barest, and L.J. Brewster A comprehensive three-dimensional radiation treatment planning system Int J Radiat Oncol Biol Phys 15 1988 481 495
6. C.S. Chui, T. LoSasso, and S. Spirou Dose calculation for photon beams with intensity modulation generated by dynamic jaw or multileaf collimations Med Phys 21 1994 1237 1244
7. D.S. Ettinger, W. Akerley, and H. Borghaei Non-small cell lung cancer, version 2.2013 J Natl Compr Cancer Netw 11 2013 645 653 quiz 653
8. T.E. Wheldon, C. Deehan, and E.G. Wheldon The linear-quadratic transformation of dose-volume histograms in fractionated radiotherapy Radiother Oncol 46 1998 285 295
9. V.T. Farewell The use of mixture models for the analysis of survival data with long-term survivors Biometrics 38 1982 1041 1046
10. T.E. Schultheiss, H.D. Thames, and L.J. Peters Effect of latency on calculated complication rates Int J Radiat Oncol Biol Phys 12 1986 1861 1865
11. S.L. Tucker, L. Dong, and W.R. Bosch Late rectal toxicity on RTOG 94-06: Analysis using a mixture Lyman model Int J Radiat Oncol Biol Phys 78 2010 1253 1260
12. J.O. Deasy, S.M. Bentzen, and A. Jackson Improving normal tissue complication probability models: The need to adopt a "data-pooling" culture Int J Radiat Oncol Biol Phys 76 2010 S151 154
13. A. Jackson, L.B. Marks, and S.M. Bentzen The lessons of QUANTEC: Recommendations for reporting and gathering data on dose-volume dependencies of treatment outcome Int J Radiat Oncol Biol Phys 76 2010 S155 160
14. A. Jackson, E.D. Yorke, and K.E. Rosenzweig The atlas of complication incidence: A proposal for a new standard for reporting the results of radiotherapy protocols Semin Radiat Oncol 16 2006 260 268
15. B.W. Cox, A. Jackson, and M. Hunt Esophageal toxicity from high-dose, single-fraction paraspinal stereotactic radiosurgery Int J Radiat Oncol Biol Phys 83 2012 e661 e667
16. Y. Oshiro, T. Aruga, and K. Tsuboi Stereotactic body radiotherapy for lung tumors at the pulmonary hilum Strahlenther Onkol 186 2010 274 279
17. S. Bral, T. Gevaert, and N. Linthout Prospective, risk-adapted strategy of stereotactic body radiotherapy for early-stage non-small-cell lung cancer: results of a phase II trial Int J Radiat Oncol Biol Phys 80 2011 1343 1349
18. H. Onishi, T. Araki, and H. Shirato Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: Clinical outcomes in 245 subjects in a Japanese multiinstitutional study Cancer 101 2004 1623 1631
19. N. Ohri, M. Werner-Wasik, and I.S. Grills Modeling local control after hypofractionated stereotactic body radiation therapy for stage I non-small cell lung cancer: A report from the Elekta collaborative lung research group Int J Radiat Oncol Biol Phys 84 2012 e379 e384
20. B.P. Rowe, D.J. Boffa, and L.D. Wilson Stereotactic body radiotherapy for central lung tumors J Thorac Oncol 7 2012 1394 1399
21. S. Senthi, C.J. Haasbeek, and B.J. Slotman Outcomes of stereotactic ablative radiotherapy for central lung tumours: A systematic review Radiother Oncol 106 2013 276 282
22. C.J. Haasbeek, F.J. Lagerwaard, and B.J. Slotman Outcomes of stereotactic ablative radiotherapy for centrally located early-stage lung cancer J Thorac Oncol 6 2011 2036 2043
23. J.Y. Chang, P.A. Balter, and L. Dong Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer Int J Radiat Oncol Biol Phys 72 2008 967 971
24. C. Chen, F. Bao, and H. Zheng Local extension at the hilum region is associated with worse long-term survival in stage I non-small cell lung cancers Ann Thorac Surg 93 2012 389 396
25. J.Y. Chang, Q.Q. Li, and Q.Y. Xu Stereotactic ablative radiation therapy for centrally located early stage or isolated parenchymal recurrences of non-small cell lung cancer: How to fly in a "no fly zone" Int J Radiat Oncol Biol Phys 88 2014 1120 1128
26. R.B. Barriger, J.A. Forquer, and J.G. Brabham A dose-volume analysis of radiation pneumonitis in non-small cell lung cancer patients treated with stereotactic body radiation therapy Int J Radiat Oncol Biol Phys 82 2012 457 462